profit from every $100 of sales.
$0$100
Clearmind Medicine
$4.53-1.95% today
-96.7% in 1 year
1-year low $4.531-year high $138.50
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Clearmind Medicine sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$3.86 million of profit last year.
SalesProfit
Clearmind Medicine vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Clearmind Medicine | No profit yet | ||
 Vertex Pharmaceuticals | 34.5× · Expensive | ||
 Regeneron Pharmaceuticals | 21.9× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.0× · Fair price |
AI analysis
An AI analyst reads Clearmind Medicine's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -6 | -6 | -6 | -6 | |
| -7 | -9 | -5 | -4 | |
| -7 | -9 | -5 | -4 | |
| -63,440.20 | -5,679.08 | -678.00 | -303.50 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1 | 6 | 7 | 6 |
| Cash | 0 | 5 | 7 | 4 |
| Total debt | 0 | 0 | 0 | 2 |
| Total liabilities | 2 | 5 | 4 | 5 |
| -1 | 1 | 3 | 1 | |
| 0 | 0 | 0 | 0 | |
| – | -690.2% | -121.0% | -100.2% | |
| 623.4% | -876.6% | -169.1% | -323.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -4 | -6 | -5 | -5 | |
| 0 | – | – | – | |
| -4 | -6 | -5 | -5 | |
| Dividends paid | 0 | – | – | – |
| – | – | – | – | |
| 1 | 1 | 1 | 1 |
Valuation
- –
- –
- –
- 0.1×
- –
- –
- 1.2×
- -206.0%
- -167.8%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -114.6%
- -182.1%
- -211.9%
- -69.2%
- -114.7%
- –
Growth
- –
- –
- +30.0%
- –
- +258.1%
Financial health
- 1.3×
- 0.00
- 0.1%
- -341.7×
- 3.79
- 3.79
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 21%of 871
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 12, 2026 | -3.32 | – | – |
| Jan 28, 2026 | -4.40 | – | – |
| Sep 11, 2025 | -10.00 | – | – |
| Jun 12, 2025 | -6.40 | – | – |
| Mar 13, 2025 | -9.60 | – | – |
| Jan 22, 2025 | -0.11 | – | – |
| Sep 16, 2024 | -0.59 | – | – |
| Jun 13, 2024 | -0.28 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
54No pass
Benjamin Graham
79Pass
Philip Fisher
40No pass
Peter Lynch
60Pass
Joel Greenblatt
50No pass
Charlie Munger
37No pass
Terry Smith
36No pass
Questions about Clearmind Medicine
Is Clearmind Medicine a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Clearmind Medicine AI analysis
What does Clearmind Medicine do?
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It is in Biotechnology.
Does Clearmind Medicine pay a dividend?
No. Clearmind Medicine does not pay a dividend at the moment.
Is Clearmind Medicine stock halal?
No. Clearmind Medicine does not pass our halal screen: its debt is 77% of its market value, at or above the 33% limit. How we check
How has Clearmind Medicine stock done over the past year?
Down 96.7% over the past twelve months, to $4.53. It traded between $4.53 and $138.50 and is 96.7% below its high.
Who are Clearmind Medicine's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with Clearmind Medicine's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.